ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
ProPhase Labs (PRPH) Misses Q3 EPS by 33c; Reports Cash and Cash Equivalents of $22.9M
November 12, 2021 8:36 AM ESTProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of ($0.26), $0.33 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.08 million.
For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.
... More


